Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 50 results in range #201 to #250.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Dai W, et al. Nat. Commun. (2017) cited as Ref 572 in DOI: 10.1038/s41392-020-0110-5: Title
  2. Gazdar AF, et al. Nat. Rev. Cancer (2017) cited as Ref 571 in DOI: 10.1038/s41392-020-0110-5: Title
  3. Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5: Title
  4. Van Groningen T, et al. Nat. Commun. (2019) cited as Ref 569 in DOI: 10.1038/s41392-020-0110-5: Title
  5. Rajakulendran N, et al. Genes Dev. (2019) cited as Ref 568 in DOI: 10.1038/s41392-020-0110-5: Title
  6. Nowell CS, et al. Nat. Rev. Cancer (2017) cited as Ref 567 in DOI: 10.1038/s41392-020-0110-5: Title
  7. Meurette O, et al. Cancer Cell (2018) cited as Ref 566 in DOI: 10.1038/s41392-020-0110-5: Title
  8. Quail DF, et al. Curr. Stem Cell Res Ther. (2012) cited as Ref 565 in DOI: 10.1038/s41392-020-0110-5: Title
  9. Schmidt M, et al. Ann. Oncol. (2010) cited as Ref 564 in DOI: 10.1038/s41392-020-0110-5: Title
  10. Niedzwiecki D, et al. J. Clin. Oncol. (2011) cited as Ref 563 in DOI: 10.1038/s41392-020-0110-5: Title
  11. Jaeger M, et al. J. Clin. Oncol. (2004) cited as Ref 562 in DOI: 10.1038/s41392-020-0110-5: Title
  12. Sebastian M, et al. Cancer Immunol. Immunother. (2007) cited as Ref 561 in DOI: 10.1038/s41392-020-0110-5: Title
  13. Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5: Title
  14. Osta WA, et al. Cancer Res. (2004) cited as Ref 559 in DOI: 10.1038/s41392-020-0110-5: Title
  15. Pemmaraju N, et al. Blood (2016) cited as Ref 558 in DOI: 10.1038/s41392-020-0110-5: Title
  16. Frankel AE, et al. Blood (2014) cited as Ref 557 in DOI: 10.1038/s41392-020-0110-5: Title
  17. He SZ, et al. Leuk. Lymphoma (2015) cited as Ref 556 in DOI: 10.1038/s41392-020-0110-5: Title
  18. Riechelmann H, et al. Oral. Oncol. (2008) cited as Ref 555 in DOI: 10.1038/s41392-020-0110-5: Title
  19. Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5: Title
  20. Postema EJ, et al. J. Nucl. Med. (2003) cited as Ref 553 in DOI: 10.1038/s41392-020-0110-5: Title
  21. Borjesson PK, et al. Clin. Cancer Res. (2003) cited as Ref 552 in DOI: 10.1038/s41392-020-0110-5: Title
  22. Nabhan C, et al. Leuk. Lymphoma (2004) cited as Ref 551 in DOI: 10.1038/s41392-020-0110-5: Title
  23. Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5: Title
  24. Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5: Title
  25. Wang J, et al. Oncotarget (2016) cited as Ref 548 in DOI: 10.1038/s41392-020-0110-5: Title
  26. Tian X, et al. Hum. Vaccin. Immunother. (2013) cited as Ref 547 in DOI: 10.1038/s41392-020-0110-5: Title
  27. Pitt JM, et al. J. Clin. Invest. (2016) cited as Ref 546 in DOI: 10.1038/s41392-020-0110-5: Title
  28. Srivastava A, et al. J. Biomed. Nanotechnol. (2016) cited as Ref 545 in DOI: 10.1038/s41392-020-0110-5: Title
  29. Munagala R, et al. Cancer Lett. (2016) cited as Ref 544 in DOI: 10.1038/s41392-020-0110-5: Title
  30. Xu J, et al. Stem Cells Int. (2018) cited as Ref 543 in DOI: 10.1038/s41392-020-0110-5: Title
  31. Figueroa J, et al. Cancer Res. (2017) cited as Ref 542 in DOI: 10.1038/s41392-020-0110-5: Title
  32. Donnarumma E, et al. Oncotarget (2017) cited as Ref 541 in DOI: 10.1038/s41392-020-0110-5: Title
  33. Shimoda M, et al. Nat. Cell Biol. (2014) cited as Ref 540 in DOI: 10.1038/s41392-020-0110-5: Title
  34. Ye J, et al. Tumor Biol. (2014) cited as Ref 539 in DOI: 10.1038/s41392-020-0110-5: Title
  35. Bronisz A, et al. Cancer Res. (2014) cited as Ref 538 in DOI: 10.1038/s41392-020-0110-5: Title
  36. Huang R, et al. Oncotarget (2017) cited as Ref 537 in DOI: 10.1038/s41392-020-0110-5: Title
  37. Dandawate PR, et al. Semin. Cancer Biol. (2016) cited as Ref 536 in DOI: 10.1038/s41392-020-0110-5: Title
  38. Rinkenbaugh AL, et al. Cells (2016) cited as Ref 535 in DOI: 10.1038/s41392-020-0110-5: Title
  39. Nakano I, et al. Semin. Cell Dev. Biol. (2015) cited as Ref 534 in DOI: 10.1038/s41392-020-0110-5: Title
  40. Andrew R, et al. Eur. J. Cancer (2014) cited as Ref 533 in DOI: 10.1038/s41392-020-0110-5: Title
  41. Melo S, et al. Cancer Cell (2014) cited as Ref 532 in DOI: 10.1038/s41392-020-0110-5: Title
  42. Rana S, et al. Neoplasia (2013) cited as Ref 531 in DOI: 10.1038/s41392-020-0110-5: Title
  43. Mrizak D, et al. J. Natl Cancer Inst. (2015) cited as Ref 530 in DOI: 10.1038/s41392-020-0110-5: Title
  44. Webber JP, et al. Oncogene (2015) cited as Ref 529 in DOI: 10.1038/s41392-020-0110-5: Title
  45. Gajos-Michniewicz A, et al. Cancer Lett. (2014) cited as Ref 528 in DOI: 10.1038/s41392-020-0110-5: Title
  46. Abels ER, et al. Cell. Mol. Neurobiol. (2016) cited as Ref 527 in DOI: 10.1038/s41392-020-0110-5: Title
  47. Lopatina T, et al. Front. Oncol. (2016) cited as Ref 526 in DOI: 10.1038/s41392-020-0110-5: Title
  48. Chow A, et al. Sci. Rep. (2014) cited as Ref 525 in DOI: 10.1038/s41392-020-0110-5: Title
  49. Alonso MA, et al. J. Cell Sci. (2001) cited as Ref 524 in DOI: 10.1038/s41392-020-0110-5: Title
  50. Pete H, et al. Proc. Natl Acad. Sci. USA (2009) cited as Ref 523 in DOI: 10.1038/s41392-020-0110-5: Title

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)